HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Kraft Selected Research

UGT1A7 UDP-glucuronosyltransferase

11/2015Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava-kava consumption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Kraft Research Topics

Disease

6Pancreatitis
01/2013 - 04/2003
3Body Weight (Weight, Body)
02/2021 - 07/2012
2Weight Loss (Weight Reduction)
02/2021 - 07/2012
2Obesity
02/2021 - 01/2011
2Inflammation (Inflammations)
01/2017 - 06/2013
2Neoplasms (Cancer)
07/2012 - 01/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2012 - 01/2011
2Cystic Fibrosis (Mucoviscidosis)
01/2011 - 06/2006
2Acute Necrotizing Pancreatitis
12/2003 - 04/2003
1Overweight
02/2021
1Type 2 Diabetes Mellitus (MODY)
02/2021
1Pathologic Constriction (Stenosis)
04/2017
1Acute Liver Failure (Fulminant Hepatic Failure)
11/2015
1Endotoxemia
06/2013
1Sepsis (Septicemia)
06/2013
1Pain (Aches)
01/2013
1Cachexia
07/2012
1Chronic Pancreatitis
01/2011
1Nausea
11/2008
1Abdominal Pain (Pain, Abdominal)
11/2008
1Renal Insufficiency (Renal Failure)
11/2008
1Pancreatic Pseudocyst
03/2008
1Lactic Acidosis
07/2006
1Jaundice (Icterus)
04/2003
1Cholangitis
04/2003
1Gallstones (Gallstone)
04/2003
1Hyperplasia
05/2002
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2002
1Gastritis
05/2002

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2011 - 06/2006
2Kazal Pancreatic Trypsin InhibitorIBA
01/2011 - 06/2006
2Anti-Bacterial Agents (Antibiotics)IBA
12/2003 - 04/2003
1Hypoglycemic Agents (Hypoglycemics)IBA
02/2021
1oxidized low density lipoproteinIBA
02/2021
1Insulin (Novolin)FDA Link
02/2021
1UGT1A7 UDP-glucuronosyltransferaseIBA
11/2015
1AlarminsIBA
06/2013
1S100A12 ProteinIBA
06/2013
1LigandsIBA
06/2013
1Peptide Hydrolases (Proteases)FDA Link
01/2013
1CalciumIBA
01/2013
1MagnesiumIBA
01/2013
1EnzymesIBA
01/2013
1Carnitine (L-Carnitine)FDA LinkGeneric
07/2012
1antineoplaston A10 (A 10)IBA
07/2012
1chymotrypsinogen CIBA
01/2011
1SmokeIBA
01/2011
1TrypsinogenIBA
01/2011
1AntioxidantsIBA
01/2011
1Trypsin InhibitorsIBA
01/2011
1Toll-Like Receptor 4IBA
08/2010
1Lipase (Acid Lipase)FDA Link
11/2008
1Metformin (Glucophage)FDA LinkGeneric
07/2006
1CytokinesIBA
06/2006
1Cathepsin BIBA
06/2006
1TrypsinIBA
06/2006
1C-Reactive ProteinIBA
12/2003
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2002
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2002
1Immunoglobulin Variable RegionIBA
05/2002

Therapy/Procedure

2Length of Stay
01/2017 - 01/2013
2Parenteral Nutrition
01/2016 - 12/2003
2Enteral Nutrition (Feeding, Tube)
12/2003 - 04/2003
1Glycemic Control
02/2021
1Therapeutics
04/2017
1Self Expandable Metallic Stents
04/2017
1Total Parenteral Nutrition
01/2016
1Catheters
03/2008
1Renal Replacement Therapy (Therapies, Renal Replacement)
07/2006
1Conservative Treatment
12/2003
1Resuscitation
04/2003
1Bed Rest (Bedrest)
04/2003
1Sphincterotomy
04/2003